Sector: MedicalCV Therapeutics, Inc. (NASDAQ: CVTX)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 269 |
Technical : | 149 |
Performance : | 72 |
Overall: | 194 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 267 |
Technical : | 158 |
Performance : | 86 |
Overall: | 203 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 267 |
Technical : | 149 |
Performance : | 94 |
Overall: | 203 |
Number of Stocks: | 305 |
Headlines
- Spotlight On: Biotech
Aug 09, 2009 03:11 PM | AAPL, AMGN, BIIB, BNT, BRL, CVD
- Trends Shaping The Health Care Industry: Part 2
Jun 06, 2009 02:14 PM | CVD, CVTX, GILD, JNJ, MRK, MYL
- Biotech Industry - Industry Outlook
Apr 16, 2009 04:59 PM | ALKS, AMAG, CELG, CEPH, CRA, CTIC
- How To Play The Healthcare Sector
Mar 30, 2009 09:39 AM | ABT, CVTX, DNA, GILD, JNJ, MRK
- Biotech Stocks: The One Sector Outperforming The S&P 500
Mar 24, 2009 09:46 AM | AMGN, CVTX, DNA, GILD, MRK, PFE
- Biotech Could Follow Pharma's M&A Lead
Mar 20, 2009 06:13 PM | CVTX, DNA, GILD, MRK, PFE, SGP
- Astellas gives up trying to acquire U.S. bio-venture CV Therapeutics
Mar 16, 2009 07:17 PM | CVTX, GILD
- Weekly Review: (03-09-2009 to 03-13-2009)
Mar 15, 2009 12:43 PM | BAC, C, CASY, CVTX, DNA, DOW
- Roche Keeps M&A Party Rolling With $46.8 Billion Deal For Genentech
Mar 13, 2009 10:39 AM | AMLN, CELG, CVTX, DNA, GENZ, GILD
- The Biotech Sector: Big Mergers Could Mean Big Gains For Biotechnology
Mar 12, 2009 06:43 PM | AMGN, BIIB, BMRN, CVTX, DNA, GENZ
- Stocks Jump Despite GE Downgrade
Mar 13, 2009 10:51 AM | CVTX, DNA, FRE, GE, GILD, GM
- Big Deals to Reshape Bay Area Biotech
Mar 12, 2009 08:51 PM | AFFY, CVTX, DNA, EXEL, GILD, JEF
- Wall Street rebounds after GE rating cut
Mar 12, 2009 11:54 AM | C, CVTX, DNA, GE, GILD
- Big Deals Reshape Bay Area Biotech Industry
Mar 12, 2009 11:51 AM | AFFY, CVTX, DNA, EXEL, GILD, PFE
- Gilead to Acquire CV Therapeutics
Mar 12, 2009 09:05 AM | CVTX, GILD
- CV Therapeutics Advises Stockholders on Astellas Offer
Feb 27, 2009 09:58 PM | CVTX
- Astellas Hints at Launching Hostile Takeover Bid for CV Therapeutics
Feb 23, 2009 12:03 PM | CVTX
- CV Therapeutics Reports $98.5 Million Loss
Feb 20, 2009 05:56 AM | CVTX
- CV Therapeutics Rejects Astellas Proposal
Feb 20, 2009 05:52 AM | CVTX
- Gilead Sciences Completes Acquisition of CV Therapeutics
Apr 17, 2009 04:17 PM | CVTX, GILD
- AnalystChoice.Com Free Investment Opinion on PPDI, MEDX, CVTX and OSIP
Apr 08, 2009 12:20 PM | CVTX, MEDX, OSIP, PPDI
- Zacks Analyst Blog Highlights: Analog Devices Inc., Gilead Sciences, CV Therapeutics, Koninklijke Philips Electronics N.V., And Skyworks Solutions, Inc.
Mar 20, 2009 06:51 AM | ADI, CVTX, GILD, PHG, SWKS
- CV Therapeutics' Board of Directors Recommends Stockholders Accept Gilead Sciences' $20.00 per Share Cash Tender Offer
Mar 18, 2009 05:05 PM | CVTX, GILD
- Run of 100% Profitable Stock Alerts Marches on for BullTrade
Mar 17, 2009 10:33 AM | C, CVTX, DELL, GOOG
- CV Therapeutics Announces Presentations at the American College of Cardiology 58th Annual Scientific Session
Mar 16, 2009 04:01 PM | CVTX
- Astellas to Terminate Offer for CV Therapeutics - Mar 16 2009 3:19AM
Mar 16, 2009 02:42 AM | CVTX
- Zacks Analyst Blog Highlights: Gilead Sciences, CV Therapeutics, The Boeing Co, Northrop Grumman Corp and eBay Inc.
Mar 13, 2009 07:17 AM | BA, CVTX, EBAY, GILD, NOC
- Zacks Industry Outlook Highlights: Roche, Genentech, Gilead Sciences and CV Therapeutics
Mar 13, 2009 07:17 AM | CVTX, DNA, GILD
- CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer
Mar 12, 2009 02:15 PM | CVTX
- Form 4/A LANGE LOUIS G For: Apr 27 (10K)
Apr 27, 2009 09:13 PM
- Form 4 SUVARI TRICIA BORGA For: Apr 14 (10K)
Apr 17, 2009 02:55 PM
- Form 4 BLACKBURN BRENT K For: Apr 14 (10K)
Apr 17, 2009 02:55 PM
- Form 4 SPIEGELMAN DANIEL K For: Apr 16 (10K)
Apr 17, 2009 02:55 PM
- Form 4 STUART LEWIS J For: Apr 16 (10K)
Apr 17, 2009 02:51 PM
- Form 4 LANGE LOUIS G For: Apr 16 (10K)
Apr 17, 2009 02:49 PM
- Form 4 SHENK THOMAS E For: Apr 14 (10K)
Apr 16, 2009 06:26 PM
- Form 4 LEE KENNETH B JR For: Apr 14 (10K)
Apr 16, 2009 06:25 PM
- Form 4 GUTSHALL THOMAS L For: Apr 14 (10K)
Apr 16, 2009 06:24 PM
- Form 4 DAVIE JOSEPH MD PHD For: Apr 14 (10K)
Apr 16, 2009 06:23 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CVTX
|
Compare to S&P
|
| YTD |
116.72 %
|
128.53 %
|
| 4 Weeks |
0.55 %
|
-6.26 %
|
| 12 Weeks |
70.45 %
|
68.09 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -46.34 %
|
|
EPS Growth in Last Year: -5.26 %
|
|
Sales Growth in Last Quarter: 9.97 %
|
|
Sales Growth in Last Quarter: 87.14 %
|
|
